|
17/06/2025
|
07:00
|
EACR 2025: Innovation in AR expression profiling
|
RNS
|
|
17/06/2025
|
07:00
|
EACR 2025: Data demonstrating DNA dual analysis
|
RNS
|
|
10/06/2025
|
07:00
|
Novel discoveries into the biology of cancer
|
RNS
|
|
09/06/2025
|
07:00
|
POSTING OF ANNUAL REPORT AND NOTICE OF AGM
|
RNS
|
|
06/06/2025
|
07:00
|
Board Changes
|
RNS
|
|
28/05/2025
|
07:00
|
Preliminary Results
|
RNS
|
|
23/05/2025
|
07:00
|
Notice of Results
|
RNS
|
|
28/04/2025
|
07:00
|
RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
|
RNS
|
|
21/03/2025
|
07:00
|
Issue of LTIP Options and Share Options
|
RNS
|
|
21/03/2025
|
07:00
|
Results of Eisai Phase 2 pilot study
|
RNS
|
|
06/02/2025
|
07:00
|
Novel findings using Parsortix
|
RNS
|
|
29/01/2025
|
07:00
|
Analysis of CTC-DNA and ctDNA using Illumina assay
|
RNS
|
|
24/01/2025
|
10:05
|
Parsortix used in research paper from ETH Zurich
|
RNS
|
|
23/01/2025
|
07:00
|
Trading Update
|
RNS
|
|
13/12/2024
|
08:43
|
HER2 presentation at SABCS
|
RNS
|
|
26/09/2024
|
07:00
|
Half-year Report
|
RNS
|
|
23/09/2024
|
07:00
|
Exclusive agreement for DNA NGS panel
|
RNS
|
|
17/09/2024
|
07:00
|
Notice of Interim Results and Webcast
|
RNS
|
|
18/07/2024
|
10:08
|
Standard form for notification of major holdings
|
RNS
|
|
12/07/2024
|
15:38
|
Standard form for notification of major holdings
|
RNS
|
|
11/07/2024
|
15:07
|
Result of 2024 Annual General Meeting
|
RNS
|
|
21/06/2024
|
07:00
|
Result of open offer
|
RNS
|
|
18/06/2024
|
14:41
|
Posting of 2023 Annual Report & Notice of the AGM
|
RNS
|
|
06/06/2024
|
16:37
|
Publication of Circular
|
RNS
|
|
05/06/2024
|
16:04
|
Results of placing and subscription
|
RNS
|
|
05/06/2024
|
07:00
|
Proposed Placing, Subscription and Open Offer
|
RNS
|
|
05/06/2024
|
07:00
|
Preliminary Results
|
RNS
|
|
03/05/2024
|
07:00
|
New commercial agreement with large pharma
|
RNS
|
|
24/04/2024
|
07:00
|
New commercial agreement with AstraZeneca
|
RNS
|
|
22/04/2024
|
07:00
|
US and EU patents for innovative CellKeep™ slide
|
RNS
|
|
10/01/2024
|
12:57
|
Standard form for notification of major holdings
|
RNS
|
|
04/01/2024
|
07:00
|
Breakthrough clinical results
|
RNS
|
|
02/01/2024
|
07:00
|
Contract announcement with Eisai Inc.
|
RNS
|
|
11/12/2023
|
07:00
|
Broker Announcement
|
RNS
|
|
09/11/2023
|
07:00
|
Trading and business update
|
RNS
|
|
07/09/2023
|
07:00
|
Interim Results for the period ended 30 June 2023
|
RNS
|
|
15/08/2023
|
07:00
|
ANGLE notice of interim results
|
RNS
|
|
28/06/2023
|
16:54
|
Result of 2023 Annual General Meeting
|
RNS
|
|
27/06/2023
|
12:24
|
Standard form for notification of major holdings
|
RNS
|
|
25/05/2023
|
07:00
|
Pharma services contract with Artios Pharma
|
RNS
|
|
22/05/2023
|
07:00
|
Board change - appointment of new Chairman
|
RNS
|
|
21/04/2023
|
07:00
|
Results for the year ended 31 December 2022
|
RNS
|
|
19/04/2023
|
07:00
|
ANGLE announces partnership with BioView
|
RNS
|
|
13/04/2023
|
07:00
|
Pharma Services Contract with Crescendo Biologics
|
RNS
|
|
03/04/2023
|
07:00
|
Notice of Preliminary Results and Webcast
|
RNS
|
|
10/03/2023
|
07:00
|
Issue of LTIP Options and Share Options
|
RNS
|
|
09/03/2023
|
15:03
|
Holding(s) in Company
|
RNS
|
|
09/02/2023
|
14:44
|
Director/PDMR shareholding
|
RNS
|
|
19/01/2023
|
07:00
|
Appointment of Non-Executive Director
|
RNS
|
|
11/01/2023
|
17:20
|
Holding(s) in Company
|
RNS
|